High Rate of Mutations in Cancers Results in Patients that are Drug Resistant or Refractory
NUMBER OF MUTATIONS PER TUMOR
TAER-TAB is a platform technology that can be used to create multifunctional antibodies directed against multiple receptor targets on cancer cells. Multifunctional antibodies, such as Bispecifics, provide the dual benefits of Targeted Therapy and Immune Therapy.
Pinetree Therapeutics c/o Ipsen Innovation Center 650 East Kendall Street Cambridge, MA 02142